IRCT20130812014333N113RecruitingPhase 2
The effect of mycophenolate mofetil in controlling the recurrence of idiopathic nephrotic syndrome in steroid-dependent children or frequent recurrence in patients referred to pediatric nephrology clinic, Imam Reza hospital
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 12
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 1 year to 12 years (—)
- Sex
- All
Inclusion Criteria
- •Ages 1 to 12 years
Exclusion Criteria
- •Patients who have been treated with MMF for at least 6 months
Investigators
Similar Trials
Not yet recruiting
Phase 4
comparing the productiveness of two different ointments in treating oral erosive lichen planusCTRI/2024/02/062184Dr L Krishna Prasad
Not yet recruiting
Phase 4
Study comparing the ability of two medications, namely oral tablets of mycophenolate mofetil and cyclophosphamide, in keeping disease well controlled in patients with frequently relapsing or steroid dependent nephrotic syndromeCTRI/2022/10/046891AIIMS New Delhi
Completed
Not Applicable
Safety and efficacy of mycophenolate mofetil in pediatric renal transplantatioISRCTN89278733Erasmus Medical Center (The Netherlands)44
Active, not recruiting
Phase 1
Influence of mycophenolate mofetil (Cellcept) on the progression of diabetic nephropathyDiabetes mellitus Type 2 with microalbuminuriaEUCTR2008-003768-20-ATMedizinische Universität Wien, Universitätsklinik f. Innere Med. III, Abt. f. Nephrologie u. Dialyse
Completed
Not Applicable
Mycophenolate mofetil treatment in a patient with frequently relapsing nephrotic syndromefrequently relapsing nephrotic syndromeJPRN-UMIN000007511Kumamoto University, Faculty of Life Sciences, Department of Pediatrics1